Acumen Pharmaceuticals, Inc. (ABOS)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Acumen Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Acumen Pharmaceuticals, Inc. at the moment.

Exchange

Nasdaq

$0M

Total Revenue

1

Employees

$183M

Market Capitalization

-2.99

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ABOS News

Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick

15d ago, source: Zacks.com on MSN

One stock that might be an intriguing choice for investors right now is Acumen Pharmaceuticals, Inc. ABOS. This is because ...

ABOS Acumen Pharmaceuticals, Inc.

12d ago, source: Seeking Alpha

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

22d ago, source: Hosted on MSN

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript March 26, 2024 Acumen Pharmaceuticals, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Acumen Pharma Partners Lonza To Advance Sabirnetug For Alzheimer's Disease Treatment

14d ago, source: Business Insider

(RTTNews) - Biopharmaceutical company Acumen Pharmaceuticals, Inc. (ABOS) on Thursday signed a collaboration agreement with Lonza, a global partner to the pharmaceutical, biotech and nutraceutical ...

Acumen Pharmaceuticals Stock (NASDAQ:ABOS), Analyst Ratings, Price Targets, Predictions

23d ago, source: Benzinga.com

There is no last downgrade for Acumen Pharmaceuticals.

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

22d ago, source: Insider Monkey

Acumen Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen. Thank you for ...

Acumen Pharmaceuticals Inc ABOS

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Q4 2023 Acumen Pharmaceuticals Inc Earnings Call

23d ago, source: Yahoo Finance

Alex Braun; Head, IR; Acumen Pharmaceuticals, Inc. Dan O'Connell; CEO; Acumen Pharmaceuticals, Inc. Eric Siemers; Chief Medical Officer; Acumen Pharmaceuticals Inc ...

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

23d ago, source: Seeking Alpha

Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...